Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIMEPREVIR vs SIMVASTATIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SIMEPREVIR vs SIMVASTATIN: Safety Overview

Metric SIMEPREVIR SIMVASTATIN
Total FAERS Reports 6,029 27,079
Deaths Reported 372 2,792
Death Rate 6.2% 10.3%
Hospitalizations 1,165 8,824
Average Patient Age 60.6 yrs 66.6 yrs
% Female Patients 43.0% 47.5%
FDA Approval Date Nov 22, 2013 Apr 14, 2009
Manufacturer N/A Aphena Pharma Solutions - Tennessee, LLC
Route N/A ORAL
Marketing Status Discontinued Prescription